4.7 Article

Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology

Related references

Note: Only part of the references are listed.
Review Economics

An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis

Nannan Li et al.

Summary: This study systematically reviewed recent economic evaluations of drugs for osteoporosis and found that most studies have room for improvement, suggesting a need for greater adherence to guideline recommendations and increased transparency in future economic evaluations.

PHARMACOECONOMICS (2021)

Article Biochemistry & Molecular Biology

Luteolin Stimulates Proliferation and Inhibits Late Differentiation of Primary Rat Calvarial Osteoblast Induced by High-dose Dexamethasone via Sema3A/NRP1/Pleixin A1

Li Zheng

Summary: The study found that Luteolin promoted the proliferation of osteoblasts, inhibited their apoptosis and late differentiation, possibly related to the up-regulated expression of Sema3A/NRP1/Plexin A1. Therefore, Luteolin may be a potential medicine for glucocorticoids-induced osteoporosis.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2021)

Article Medicine, Research & Experimental

Total flavonoids of Rhizoma Drynariae combined with calcium attenuate osteoporosis by reducing reactive oxygen species generation

Panyun Mu et al.

Summary: The study demonstrated that TFRD and CaCO3 significantly increased antioxidant capacity in rats with osteoporosis, improved bone mineral density, and reduced bone mineral loss. Both histopathological evaluation and biochemical observations supported the positive effects of TFRD and CaCO3 in preventing and treating osteoporosis.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Review Medicine, General & Internal

The epidemiology of osteoporosis

Michael A. Clynes et al.

BRITISH MEDICAL BULLETIN (2020)

Review Geriatrics & Gerontology

Pharmacological Therapy of Osteoporosis: What's New?

Giovanni Iolascon et al.

CLINICAL INTERVENTIONS IN AGING (2020)

Review Geriatrics & Gerontology

How to manage osteoporosis before the age of 50

S. Rozenberg et al.

MATURITAS (2020)

Review Nutrition & Dietetics

Dietary Intake of Vitamin D from Dairy Products Reduces the Risk of Osteoporosis

Valeria Polzonetti et al.

NUTRIENTS (2020)

Review Medicine, General & Internal

Osteoporosis in Older Adults

Catherine Bree Johnston et al.

MEDICAL CLINICS OF NORTH AMERICA (2020)

Review Medicine, General & Internal

Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review

Patrice Fardellone et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Endocrinology & Metabolism

Projection of osteoporosis-related fractures and costs in China: 2010-2050

L. Si et al.

OSTEOPOROSIS INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

Loss of Cbl-PI3K Interaction Enhances Osteoclast Survival due to p21-Ras Mediated PI3K Activation Independent of Cbl-b

Naga Suresh Adapala et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2014)

Article Integrative & Complementary Medicine

Population Pharmacokinetics of Naringin in Total Flavonoids of Drynaria Fortunei (Kunze) J. Sm. in Chinese Women with Primary Osteoporosis

Wang Jian-nong et al.

CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2012)

Review Integrative & Complementary Medicine

Interventional value of total flavonoids from Rhizoma Drynariae on Cathepsin K, a potential target of osteoporosis

Shi Xiao-lin et al.

CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2011)

Article Biochemistry & Molecular Biology

The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss

Tae-Ho Kim et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells

SM Nielsen-Preiss et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2003)